News
Dorling has led global teams covering more than 150 countries and currently serves on the Advisory Board for the Robinson ...
With the dust now settled on the euphoric market rebound following President Donald Trump's trade war climb-down, investors ...
PrimeC has demonstrated promising results in the 18-month Phase 2b trial, with data highlighting its potential as a disease-modifying therapy for ALS. The trial revealed a marked reduction in ALS ...
U.S. President Donald Trump's U-turn on tariffs has rained yet more volatility on markets, leaving investors skidding from ...
Samudrala discussed the Computational Analysis of Novel Drug Opportunities (CANDO) platform, which speeds targeted drug ...
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced the presentation of data yesterday highlighting BRIUMVI ® (ublituximab-xiiy) in patients with relapsing ...
Washington is now pursuing negotiations with its trading partners and most retaliatory measures have been put on ice. But the ...
President Donald Trump has consistently emphasized the trade deficit as a measure of unfair practices by other countries that ...
Hyderabad: As a follow up on the UN Women’s theme ‘For All Women and Girls – Rights Equality Empowerment’, the Hyderabad City ...
Minister for municipal administration and urban development P Narayana addressing a one-day workshop for municipal ...
On 2 April, the Trump administration announced sweeping tariffs that were more aggressive than many had expected. Then on 9 ...
Oral triptans are considered the industry gold standard acute treatments and there are currently seven approved, all with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results